[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024

July 2019 | 235 pages | ID: CBCC318BF68EN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
“Increasing funding for cell-based research, growing benefits of the cell culture-based vaccines, and rising demand for monoclonal antibodies are expected to drive the overall growth of the cell culture market.”

The cell culture market is expected to reach USD 29.2 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 12.7% during the forecast period. This market is experiencing significant growth due to the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, growing focus on personalized medicine, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.

“Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period.”

Based on end user, the cell culture market is segmented into research institutes, pharmaceutical & biotechnology companies, cell banks, and hospitals & diagnostic laboratories. In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for pharmaceutical and biotechnology companies.

“Biopharmaceutical production to witness the highest growth in the cell culture market.”

Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is also expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increasing demand for monoclonal antibodies (mAbs).

“North America to dominate the market during the forecast period.”

Geographically, the cell culture market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology and pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, strong government support, and conferences and symposiums that create awareness on the latest trends in cell culture technology are the key factors driving the growth of the cell culture market in North America.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
  • By Designation - C-level: 33%, D-level: 40%, and Others: 27%
  • By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, Rest of the World: 17%
List of Companies Profiled in the Report
  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • GE Healthcare (US)
  • Lonza (Switzerland)
  • Becton, Dickinson and Company (US)
  • Corning Incorporated (US)
  • Eppendorf AG (Germany)
  • HiMedia Laboratories (India)
  • Sartorius AG (Germany)
  • PromoCell GmbH (Germany)
  • Danaher Corporation (US)
  • FUJIFILM Irvine Scientific (US)
  • InvivoGen (US)
  • CellGenix GmbH (Germany)
  • Miltenyi Biotec (Germany)
Research Coverage:

This report provides a detailed picture of the global cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
2.2 SECONDARY DATA
  2.2.1 SECONDARY SOURCE
2.3 PRIMARY DATA
  2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 CELL CULTURE: MARKET OVERVIEW
4.2 ASIA PACIFIC: CELL CULTURE MARKET SHARE, BY END USER AND COUNTRY (2019)
4.3 CELL CULTURE SERA, MEDIA, & REAGENTS MARKET, BY TYPE (USD BILLION)
4.4 CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
4.5 CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION)
4.6 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 MARKET DRIVERS
    5.2.1.1 Growing awareness about the benefits of cell culture-based vaccines
    5.2.1.2 Increasing demand for monoclonal antibodies
    5.2.1.3 Funding for cell-based research
    5.2.1.4 Growing preference for single-use technologies
    5.2.1.5 Launch of advanced cell culture products
    5.2.1.6 Growing focus on personalized medicine
  5.2.2 MARKET RESTRAINTS
    5.2.2.1 High cost of cell biology research
    5.2.2.2 Lack of infrastructure for cell-based research in emerging economies
  5.2.3 MARKET OPPORTUNITIES
    5.2.3.1 Growing demand for 3D cell culture
    5.2.3.2 Increased risk of pandemics and communicable diseases
    5.2.3.3 Emerging economies

6 CELL CULTURE MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 CONSUMABLES
  6.2.1 SERA, MEDIA, AND REAGENTS
    6.2.1.1 Media
      6.2.1.1.1 Serum-free media
        6.2.1.1.1.1 Lack of sera eliminates the risk of contamination by viruses
      6.2.1.1.2 Classical media & salts
        6.2.1.1.2.1 Classical media is commonly used in diagnostics and manufacturing
      6.2.1.1.3 Stem cell culture media
        6.2.1.1.3.1 Stem cell culture media will witness the highest growth in the APAC market
      6.2.1.1.4 Specialty media
        6.2.1.1.4.1 Specialty media is suitable for specific, selective cell types
    6.2.1.2 Reagents
      6.2.1.2.1 Supplements & growth factors
        6.2.1.2.1.1 Supplements such as amino acids play a key role in inducing cell growth
      6.2.1.2.2 Buffers & chemicals
        6.2.1.2.2.1 Chemical buffers are widely used, but are expensive and can be toxic
      6.2.1.2.3 Cell dissociation reagents
        6.2.1.2.3.1 Dissociation reagents can be enzymatic or non-enzymatic
      6.2.1.2.4 Balanced salt solutions
        6.2.1.2.4.1 Salt solutions find wide applications in life sciences
      6.2.1.2.5 Attachment & matrix factors
        6.2.1.2.5.1 Development of cells is dependent on attachment factors
      6.2.1.2.6 Antibiotics/Antimycotics
        6.2.1.2.6.1 Possibility of toxicity and contamination risks make long-term use of antibiotics/antimycotics conditional
      6.2.1.2.7 Contamination detection kits
        6.2.1.2.7.1 Kits provide results in hours, much faster than direct culture methods
      6.2.1.2.8 Cryoprotective reagents
        6.2.1.2.8.1 Inorganic expansions are a favored strategy for companies in this market
      6.2.1.2.9 Other cell culture reagents
    6.2.1.3 Sera
      6.2.1.3.1 Fetal bovine sera
        6.2.1.3.1.1 Use of FBS is associated with ethical issues
      6.2.1.3.2 Adult bovine sera
        6.2.1.3.2.1 ABS is used as a biochemical agent in IVD
      6.2.1.3.3 Other animal sera
  6.2.2 VESSELS
    6.2.2.1 Roller/roux bottles
      6.2.2.1.1 Roller bottles offer an economical means of cultivating large cell volumes
    6.2.2.2 Cell factory systems/cell stacks
      6.2.2.2.1 Cell stacks require special handling equipment and skilled expertise
    6.2.2.3 Multiwell plates
      6.2.2.3.1 Larger well formats allow for greater culture volumes
    6.2.2.4 Flasks
      6.2.2.4.1 Disposable flasks are in greater demand among end users
    6.2.2.5 Petri dishes
      6.2.2.5.1 Wide usage of Petri dishes is attributed to their ease of use
  6.2.3 BIOREACTOR ACCESSORIES
6.3 EQUIPMENT
  6.3.1 SUPPORTING EQUIPMENT
    6.3.1.1 Filtration systems
      6.3.1.1.1 Growing research in cell biology is a key factor driving market growth
    6.3.1.2 Cell counters
      6.3.1.2.1 Automated cell counters are witnessing growing demand
    6.3.1.3 Carbon dioxide incubators
      6.3.1.3.1 Incubators provide control over atmospheric conditions for best effect
    6.3.1.4 Centrifuges
      6.3.1.4.1 Technological advances have enabled the development of faster, more effective centrifuges
    6.3.1.5 Autoclaves
      6.3.1.5.1 Autoclaves sterilize equipment and supplies for use
    6.3.1.6 Microscopes
      6.3.1.6.1 Inverted microscopes are widely used in cell culture processes
    6.3.1.7 Biosafety cabinets
      6.3.1.7.1 Cabinets are classified into three classes based on protection offered
    6.3.1.8 Other supporting equipment
  6.3.2 BIOREACTORS
    6.3.2.1 Conventional bioreactors
      6.3.2.1.1 Conventional bioreactors hold the largest share of the bioreactors market
    6.3.2.2 Single-use bioreactors
      6.3.2.2.1 Convenience, ease of use, and flexibility are driving demand for single-use bioreactors
  6.3.3 STORAGE EQUIPMENT
    6.3.3.1 Refrigerators & freezers
      6.3.3.1.1 Refrigerators & freezers are used for both short and long-term storage
    6.3.3.2 Cryostorage systems
      6.3.3.2.1 Benefits of long-term preservation of cell cultures are driving market growth

7 CELL CULTURE MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 BIOPHARMACEUTICAL PRODUCTION
  7.2.1 THERAPEUTIC PROTEINS
    7.2.1.1 Growing applications of recombinant proteins to drive this segment
  7.2.2 VACCINE PRODUCTION
    7.2.2.1 Rising incidence of disease outbreaks to drive the market for vaccine production
7.3 DIAGNOSTICS
  7.3.1 CELL CULTURES ARE USED IN THE DIAGNOSIS OF VIRAL DISEASES
7.4 DRUG SCREENING AND DEVELOPMENT
7.5 STEM CELL RESEARCH
  7.5.1 STRINGENT REGULATIONS TO CONDUCT CLINICAL TRIALS FOR NEW STEM CELL-BASED THERAPIES ON HUMAN SUBJECTS IS RESTRAINING THE GROWTH OF THIS SEGMENT
7.6 TISSUE ENGINEERING & REGENERATIVE MEDICINE
7.7 OTHER APPLICATIONS

8 CELL CULTURE MARKET, BY END USER

8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  8.2.1 INCREASING USE OF SINGLE-USE TECHNOLOGIES IS DRIVING THE GROWTH OF THE CELL CULTURE MARKET FOR THIS SEGMENT
8.3 HOSPITALS AND DIAGNOSTIC LABORATORIES
  8.3.1 INCREASING AWARENESS FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THIS SEGMENT
8.4 RESEARCH INSTITUTES
  8.4.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH PROJECTS AND HIGH PREVALENCE OF CANCER TO DRIVE THE CELL CULTURE MARKET FOR RESEARCH INSTITUTES
8.5 CELL BANKS
  8.5.1 INCREASING AWARENESS OF PRESERVING STEM CELLS TO DRIVE THIS SEGMENT

9 CELL CULTURE MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 US
    9.2.1.1 US to dominate the North American cell culture market
  9.2.2 CANADA
    9.2.2.1 Advancement in the field of regenerative medicine to drive the cell culture market in Canada
9.3 EUROPE
  9.3.1 GERMANY
    9.3.1.1 Increasing investment by various key players and growing funding from government organizations to drive the market
  9.3.2 FRANCE
    9.3.2.1 Support from government and private investors to drive the market for cell culture in France
  9.3.3 UK
    9.3.3.1 Growth in the life science industry to drive the market for cell culture in the UK
  9.3.4 ITALY
    9.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell culture products
  9.3.5 SPAIN
    9.3.5.1 Increasing funding from private and public organizations to aid market growth
  9.3.6 ROE
9.4 ASIA PACIFIC
  9.4.1 JAPAN
    9.4.1.1 Strategic developments by companies to drive the market for cell culture in Japan
  9.4.2 CHINA
    9.4.2.1 Government initiatives and strategic initiatives by key players to strengthen the biotechnology industry in China
  9.4.3 INDIA
    9.4.3.1 Growth initiatives to promote life science industry to drive the market for cell culture in India
  9.4.4 ROAPAC
9.5 REST OF THE WORLD (ROW)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2018
10.3 COMPETITIVE SCENARIO
  10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016–2019)
  10.3.2 PRODUCT LAUNCHES (2016–2019)
  10.3.3 EXPANSIONS (2016–2019)
  10.3.4 ACQUISITIONS (2016–2019)
10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
  10.4.1 VENDOR INCLUSION CRITERIA
  10.4.2 VANGUARDS
  10.4.3 INNOVATORS
  10.4.4 DYNAMIC PLAYERS
  10.4.5 EMERGING PLAYERS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 BECTON, DICKINSON AND COMPANY
11.2 CELLGENIX
11.3 CORNING
11.4 DANAHER
11.5 EPPENDORF
11.6 FUJIFILM IRVINE SCIENTIFIC (ACQUIRED BY FUJIFILM CORPORATION)
11.7 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
11.8 HI-MEDIA LABORATORIES
11.9 INVIVOGEN
11.10 LONZA GROUP AG
11.11 MERCK KGAA
11.12 MILTENYI BIOTEC
11.13 PROMOCELL
11.14 SARTORIUS AG
11.15 THERMO FISHER SCIENTIFIC
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 DISCUSSION GUIDE
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
TABLE 2 APPROVED MONOCLONAL ANTIBODIES BY EMA/FDA FOR THERAPEUTIC USE
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
TABLE 4 CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 5 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 10 CELL CULTURE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 SERUM-FREE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 SPECIALTY MEDIA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 16 CELL CULTURE REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 SUPPLEMENTS AND GROWTH FACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 BUFFERS & CHEMICALS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 OTHER CELL CULTURE REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 27 CELL CULTURE SERA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 28 FETAL BOVINE SERA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 ADULT BOVINE SERA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 OTHER ANIMAL SERA MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 31 VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 32 VESSELS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 34 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 35 MULTIWELL PLATES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 FLASKS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 37 PETRI DISHES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 38 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 39 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 41 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 42 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 43 FILTRATION SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 44 CELL COUNTERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 45 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 46 CENTRIFUGES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 AUTOCLAVES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 48 MICROSCOPES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 49 BIOSAFETY CABINETS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 50 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 51 CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 52 CELL CULTURE BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 53 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 54 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 55 CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 CELL CULTURE STORAGE EQUIPMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 57 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 58 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 59 CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 60 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2017–2024 (USD MILLION)
TABLE 61 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2017–2024 (USD MILLION)
TABLE 62 THERAPEUTIC PROTEINS MARKET, BY REGION, 2018-2023 (USD MILLION)
TABLE 63 VACCINE PRODUCTION MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 64 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2017–2024 (USD MILLION)
TABLE 65 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2017–2024 (USD MILLION)
TABLE 66 CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY REGION, 2017–2024 (USD MILLION)
TABLE 67 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2017–2024 (USD MILLION)
TABLE 68 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 69 CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 70 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 71 CELL CULTURE MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 72 CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 73 CELL CULTURE MARKET FOR CELL BANKS, BY REGION, 2017–2024 (USD MILLION)
TABLE 74 CELL CULTURE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 75 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 76 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 77 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 80 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 81 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 83 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 84 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 85 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 NORTH AMERICA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 87 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 88 NORTH AMERICA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 89 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 90 US: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 91 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 93 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 94 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 95 US: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 99 US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100 US: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 101 US: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 102 US: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 103 US: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 104 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 105 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 106 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 107 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 108 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 109 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 110 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 111 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 112 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 113 CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 114 CANADA: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 115 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 116 CANADA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 CANADA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 118 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 119 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 120 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 121 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 122 EUROPE: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 123 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 124 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 125 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 126 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 127 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 128 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 129 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 130 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 131 EUROPE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 132 EUROPE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 133 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 134 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 135 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 136 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 137 GERMANY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 138 GERMANY: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 139 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 140 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 142 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 143 FRANCE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 144 FRANCE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 145 UK: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 146 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 147 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 148 UK: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 149 UK: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 150 UK: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 151 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 152 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 153 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 154 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 155 ITALY: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 156 ITALY: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 157 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 158 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 159 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 160 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 161 SPAIN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 162 SPAIN: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 163 ROE: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 164 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 165 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 166 ROE: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 167 ROE: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 168 ROE: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 169 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 170 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 171 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 172 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 173 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 174 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 175 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 176 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 177 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 178 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 179 ASIA PACIFIC: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 180 ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 181 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 182 ASIA PACIFIC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 183 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 184 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 185 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 186 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 187 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 188 JAPAN: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 189 JAPAN: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 190 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 191 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 192 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 193 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 194 CHINA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 195 CHINA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 196 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 197 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 198 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 199 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 200 INDIA: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 201 INDIA: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 202 ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 203 ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 204 ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 205 ROAPAC: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 206 ROAPAC: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 207 ROAPAC: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 208 ROW: CELL CULTURE MARKET, BY PRODUCT, 2017–2024 (USD MILLION)
TABLE 209 ROW: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 210 ROW: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 211 ROW: CELL CULTURE MEDIA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 212 ROW: CELL CULTURE REAGENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 213 ROW: CELL CULTURE SERA MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 214 ROW: CELL CULTURE VESSELS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 215 ROW: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 216 ROW: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 217 ROW: CELL CULTURE BIOREACTORS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 218 ROW: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 219 ROW: CELL CULTURE MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 220 ROW: CELL CULTURE BIOPHARMACEUTICAL PRODUCTION MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 221 ROW: CELL CULTURE MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 222 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
TABLE 223 EXCHANGE RATES (USED FOR THE CONVERSION OF JPY YEN TO USD)
TABLE 224 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)

Cell  Culture  is  the  process  in  which  cells  from  microbes,  plants,  insects  or  animal  are  grown  in  an  artificial environment  under  controlled  conditions.  Although  the  conditions  under  which  these  cells  are  cultured  vary widely  with  the  type  of  cells,  a  regulated  chemical  environment  which  includes  pH,  osmotic  pressure,  and temperature along with a substrate that provides nutrients, growth factors, hormones, and gases are invariably a part of all cultures. 

This report segments the cell culture market into two submarkets, namely, the cell culture equipment market and  the  cell  culture  media,  sera,  and  reagents  market.  The  cell  culture  equipment  market  consists  of  five equipment  segments,  namely,  lab  equipment,  bio-safety  cabinets,  consumables,  storage  equipment,  and sterilization  equipment.  On  the  other  hand,  the  cell  culture  media,  sera,  and  reagents  market  consists  of  six segments, namely, serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents.  The  report  segments  the  cell  culture  market  on  the  basis  of  applications  and  geographies.  The application  segment  included  in  this  report  are  biopharmaceutical  production,  tissue  culture  and  engineering, vaccine production, drug screening and development, gene therapy, toxicity testing, cancer research, and other applications. The geographic segments included in this report are North America, Europe, APAC, and Rest of the World (RoW).

Growth in the biopharmaceuticals market is a major driver for the cell culture market. It is the most integral part of  biopharmaceutical  development,  bio-processing,  and  manufacturing.  As  the  development  of  vaccines  is another important growth driver for this market, influenza vaccines were previously developed with the help of egg-based technology. However, due its labor-intensive approach it has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture. The cell culture market is expected to witness moderate growth in the next five years. 

The  market  is  also  driven  by  the  use  of  animal-derived  component-free  media  and  reagents  and  the  growing demand for advanced biologics and biosimilars from the biopharmaceutical industry. The increasing demand for automated  cell culture  processes and  systems will  also  be  an  impetus for  growth. The  market  is  also  likely  to notice a shift towards contract manufacturing and research.

The serum-free media market is expected to be the fastest growing segment. Adoption of serum-free, chemically defined, and specialty media is expected to be high being an impetus of growth for this segment. The bioreactor and culture system segments form the most attractive markets in the consumables segment, in terms of revenue as well as CAGR.

Market players are making significant investments in Asia due to a favorable scenario for stem cell research. The cell culture market is fairly consolidated with major players being Becton, Dickinson and Company (U.S.), Corning (U.S.),   Eppendorf   (Germany),   General   Electric   (U.S.),   Lonza   (Switzerland),   Merck   (Germany),   Promocell (Germany), Sartorius (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific (U.S.).



More Publications